ROC curve analysis revealed that ACSL6, SLC11A2, HMOX1, SLC38A1, AKR1C3, and the risk score model had AUC values of 0.949, 0.934, 0.868, 0.842, and 0.975 respectively (Figures 4C-H); thus confirming their diagnostic value in CML cases. This evidence concerns the gene SLC38A1 and chronic myelogenous leukemia, BCR-ABL1 positive.